Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The functional heart is comprised of distinct mesoderm-derived lineages including cardiomyocytes, endothelial cells and vascular smooth muscle cells. Studies in the mouse embryo and the mouse embryonic stem cell differentiation model have provided evidence indicating that these three lineages develop from a common Flk-1(+) (kinase insert domain protein receptor, also known as Kdr) cardiovascular progenitor that represents one of the earliest stages in mesoderm specification to the cardiovascular lineages. To determine whether a comparable progenitor is present during human cardiogenesis, we analysed the development of the cardiovascular lineages in human embryonic stem cell differentiation cultures. Here we show that after induction with combinations of activin A, bone morphogenetic protein 4 (BMP4), basic fibroblast growth factor (bFGF, also known as FGF2), vascular endothelial growth factor (VEGF, also known as VEGFA) and dickkopf homolog 1 (DKK1) in serum-free media, human embryonic-stem-cell-derived embryoid bodies generate a KDR(low)/C-KIT(CD117)(neg) population that displays cardiac, endothelial and vascular smooth muscle potential in vitro and, after transplantation, in vivo. When plated in monolayer cultures, these KDR(low)/C-KIT(neg) cells differentiate to generate populations consisting of greater than 50% contracting cardiomyocytes. Populations derived from the KDR(low)/C-KIT(neg) fraction give rise to colonies that contain all three lineages when plated in methylcellulose cultures. Results from limiting dilution studies and cell-mixing experiments support the interpretation that these colonies are clones, indicating that they develop from a cardiovascular colony-forming cell. Together, these findings identify a human cardiovascular progenitor that defines one of the earliest stages of human cardiac development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CMs can reliably be derived from human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) using protocols that involve timed application of GFs or small molecules, that are designed to recapitulate developmental pathways.”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [148]
Citations
Cites
Laflamme, M. A., Chen, K. Y., Naumova, A. V., Muskheli, V., Fugate, J. A., Dupras, S. K., Reinecke, H., Xu, C., Hassanipour, M., Police, S., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1327 · Cited by 2,206
Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse.
Winnier, G., Blessing, M., Labosky, P. A., & Hogan, B. L. (1995) · Genes & Development · doi:10.1101/gad.9.17.2105 · Cited by 1,788
Cai, C.-L., Liang, X., Shi, Y., Chu, P.-H., Pfaff, S. L., Chen, J., & Evans, S. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00363-0 · Cited by 1,610
Moretti, A., Caron, L., Nakano, A., Lam, J. T., Bernshausen, A., Chen, Y., Qyang, Y., Bu, L., Sasaki, M., Martin-Puig, S., et al. (2006) · Cell · doi:10.1016/j.cell.2006.10.029 · Cited by 1,038
Bearzi, C., Rota, M., Hosoda, T., Tillmanns, J., Nascimbene, A., De Angelis, A., Yasuzawa-Amano, S., Trofimova, I., Siggins, R. W., LeCapitaine, N., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706760104 · Cited by 980
Requirement for Wnt3 in vertebrate axis formation
Liu, P., Wakamiya, M., Shea, M. J., Albrecht, U., Behringer, R. R., & Bradley, A. (1999) · Nature Genetics · doi:10.1038/11932 · Cited by 901
Lints, T. J., Parsons, L. M., Hartley, L., Lyons, I., & Harvey, R. P. (1993) · Development · doi:10.1242/dev.119.2.419 · Cited by 861
Conlon, F. L., Lyons, K. M., Takaesu, N., Barth, K. S., Kispert, A., Herrmann, B., & Robertson, E. J. (1994) · Development · doi:10.1242/dev.120.7.1919 · Cited by 770
Kattman, S. J., Huber, T. L., & Keller, G. M. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.10.002 · Cited by 729
Self-citationRole of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum
de la Pompa, J. L., Timmerman, L. A., Takimoto, H., Yoshida, H., Elia, A. J., Samper, E., Potter, J., Wakeham, A., Marengere, L., Langille, B. L., et al. (1998) · Nature · doi:10.1038/32419 · Cited by 660
Cited by
Items 501–600 of 1,000
Role of Nitric Oxide Signaling in Endothelial Differentiation of Embryonic Stem Cells
Huang, N. F., Fleißner, F., Sun, J. S., & Cooke, J. P. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0417 · Cited by 46
“…ESCs have been successfully differentiated into cardiovascular lineages such as endothelial cells (ECs), cardiomyocytes, and vascular smooth muscle cells, and have been shown to have functional benefi t in pre-clinical models of myocardial infarction and peripheral arterial disease [ 3–6 ].”
Anastasia, L., Pelissero, G., Venerando, B., & Tettamanti, G. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.14 · Cited by 48
Induced Pluripotent Stem Cells for the Study of Cardiovascular Disease
Savla, J. J., Nelson, B., Perry, C. N., & ADLER, E. D. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.038 · Cited by 48
Self-citationES and iPS cell research for cardiovascular regeneration
Yamashita, J. K. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.04.004 · Cited by 44
Sacrificial layer technique for axial force post assay of immature cardiomyocytes
Taylor, R. E., Kim, K., Sun, N., Park, S., Sim, J. Y., Fajardo, G., Bernstein, D., Wu, J. C., & Pruitt, B. L. (2012) · Biomedical Microdevices · doi:10.1007/s10544-012-9710-3 · Cited by 46
Choe, J., Kim, J., Park, K.-Y., Choi, C.-H., & Kim, S. (2015) · Rheumatology · doi:10.1093/rheumatology/kev422 · Cited by 47
Barbuti, A., Benzoni, P., Campostrini, G., & Dell'Era, P. (2016) · Developmental Dynamics · doi:10.1002/dvdy.24455 · Cited by 42
“, 2011), together with the finding that cardiac specification can be obtained by inhibiting Wnt signaling, using either DKK1 (Yang et al., 2008) or the small molecules IWRs (Ren et al.”
BackgroundInfluentialA Multimaterial Microphysiological Platform Enabled by Rapid Casting of Elastic Microwires
Zhao, Y., Wang, E. Y., Huyer, L. D., Liao, Y., Yeager, K. J., Vunjak‐Novakovic, G., Radisic, M., & Zhang, B. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801187 · Cited by 46
Cardiac Cell Therapy for Heart Repair: Should the Cells Be Left Out?
Zhu, D., & Cheng, K. (2021) · Cells · doi:10.3390/cells10030641 · Cited by 49
“Flk1+ cells and Mesp1+ cells represent another two types of CPCs identified in heart [33,59,60].”
BackgroundConcise Review: The Role of C-kit Expressing Cells in Heart Repair at the Neonatal and Adult Stage
Hesse, M., Fleischmann, B. K., & Kotlikoff, M. I. (2014) · Stem Cells · doi:10.1002/stem.1696 · Cited by 45
Moon, S., Kim, J. S., Park, S., Lim, J., Lee, H., Lee, S. M., & Chung, H. (2010) · Stem Cell Research · doi:10.1016/j.scr.2010.08.006 · Cited by 45
Techniques for the induction of human pluripotent stem cell differentiation towards cardiomyocytes
Lewandowski, J., Kolanowski, T. J., & Kurpisz, M. K. (2016) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2117 · Cited by 48
“The most promising agents are BMP4, activin A, FGF2 and vascular endothelial growth factor (VEGF) (Yang et al., 2008) following temporal administration of WNT and agonists or antagonists of WNT.”
BackgroundInfluentialMesp1 Marked Cardiac Progenitor Cells Repair Infarcted Mouse Hearts
Liu, Y., Chen, L., Díaz, A. D., Benham, A. L., Xu, X., Wijaya, C. S., Fa’ak, F., Luo, W., Soibam, B., Azares, A. R., et al. (2016) · Scientific Reports · doi:10.1038/srep31457 · Cited by 43
Robbins, E. R., Pins, G. D., Laflamme, M. A., & Gaudette, G. R. (2020) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36971 · Cited by 48
“…cells to exhibit characteristics of embryonic stem cells (Takahashi & Yamanaka, 2006; Yu, Smuga-Otto, Vodyanik, et al., 2007), and differentiated into cardiomyocytes with induction of activin-A and bone morphogenetic protein-4, as previously described (Kattman et al., 2011; Yang et al., 2008).”
BackgroundMesenchymal Stem Cells for Cardiac Regeneration: from Differentiation to Cell Delivery
Gupta, S., Sharma, A., Archana, S. S., & Verma, R. S. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10168-0 · Cited by 47
Li, J., Feng, X., & Wei, X. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02905-0 · Cited by 47
Molecular beacon–enabled purification of living cells by targeting cell type–specific mRNAs
Wile, B. M., Ban, K., Yoon, Y., & Bao, G. (2014) · Nature Protocols · doi:10.1038/nprot.2014.154 · Cited by 43
Gibb, N., Lavery, D. L., & Hoppler, S. (2013) · Development · doi:10.1242/dev.088047 · Cited by 42
Stubenvoll, A., Rice, M., Wietelmann, A., Wheeler, M., & Braun, T. W. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu498 · Cited by 42
Buikema, J. W., van der Meer, P., Sluijter, J. P. G., & Domian, I. J. (2013) · Stem Cells · doi:10.1002/stem.1467 · Cited by 47
Understanding the Journey of Human Hematopoietic Stem Cell Development
Kumar, A., D'Souza, S. S., & Thakur, A. S. (2019) · Stem Cells International · doi:10.1155/2019/2141475 · Cited by 47
“The last one is cardiovascular progenitors which have endothelial and cardiomyocyte potentials [128].”
BackgroundYechikov, S., Kao, H. K. J., Chang, C., Pretto, D. I., Zhang, X.-D., Sun, Y., Smithers, R. L., Sirish, P., Nolta, J. A., Chan, J. W., et al. (2020) · Stem Cell Research · doi:10.1016/j.scr.2020.102043 · Cited by 43
“Directed differentiation of CMs from hPSCs has greatly improved in recent years (Lian et al., 2012, 2013; Yang et al., 2008).”
BackgroundHaque, M., Siegel, R. J., Fox, D. A., & Ahmed, S. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa609 · Cited by 46
Human iPSCs and Genome Editing Technologies for Precision Cardiovascular Tissue Engineering
Gähwiler, E. K. N., Motta, S. E., Martin, M., Nugraha, B., Hoerstrup, S. P., & Emmert, M. Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.639699 · Cited by 45
“This induced hiPSCs to spontaneously aggregate and form embryoid bodies (EBs), thus mimicking embryogenesis (Maltsev et al., 1993; Yang et al., 2008).”
BackgroundSlukvin, I. I., & Uenishi, G. I. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.11.007 · Cited by 42
Dunn, K. K., & Palecek, S. P. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00110 · Cited by 41
Induced pluripotent stem cells for cardiac repair
Zwi‐Dantsis, L., & Gepstein, L. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1078-2 · Cited by 45
“resulted in significant enhancement of cardiomyogenesis (40–50 % cardiomyocytes) [28].”
BackgroundCardiomyogenesis Modeling Using Pluripotent Stem Cells: The Role of Microenvironmental Signaling
Leitolis, A., Robert, A. W., Pereira, I. T., Correa, A., & Stimamiglio, M. A. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00164 · Cited by 45
“Concentration and time of addition or removal of specific factors, such as BMP4, activin A and Wnt modulators, are critical for cardiac lineage specification and were adapted in the protocols to improve efficiency (Yang et al., 2008; Kattman et al., 2011; Ren et al., 2011).”
BackgroundSignaling Pathways and Gene Regulatory Networks in Cardiomyocyte Differentiation
Parikh, A., Wu, J., Blanton, R. M., & Tzanakakis, E. S. (2015) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2014.0662 · Cited by 45
“It is argued(48,96) that activin A and BMP4 may modulate endogenous Wnt activity, yet separate requirements and finetuning of these pathways are demonstrated by others.(84,97) For the Wnt pathway, appropriate selection of timing and duration has proven to be critical, whereas for the activin A and BMP4 cascades, the c…”
BackgroundMethodInfluentialTung, J. C., Paige, S. L., Ratner, B. D., Murry, C. E., & Giachelli, C. M. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.01.011 · Cited by 42
“KDR+ cardiovascular progenitor cells are a multipotent cell population with the capacity to differentiate into endothelial, smooth muscle, and cardiac cell types (Yang et al., 2008).”
BackgroundMethodLam, A. T., Chen, A. K.-L., Li, J., Birch, W. R., Reuveny, S., & Oh, S. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt498 · Cited by 42
“hPSCs have been differentiated with growth factor-based [7-10] or small molecule-based [11-15] differentiation protocols.”
MethodWuriyanghai, Y., Makiyama, T., Sasaki, K., Kamakura, T., Yamamoto, Y., Hayano, M., Harita, T., Nishiuchi, S., Chen, J., Kohjitani, H., et al. (2018) · Heart Rhythm · doi:10.1016/j.hrthm.2018.05.028 · Cited by 40
In vitro models of the human heart
Hofbauer, P., Jahnel, S. M., & Mendjan, S. (2021) · Development · doi:10.1242/dev.199672 · Cited by 35
Pluripotent Stem Cell Derived Cardiomyocytes for Cardiac Repair
Lundy, S. D., Gantz, J. A., Pagan, C. M., Filice, D., & Laflamme, M. A. (2014) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-014-0319-0 · Cited by 45
Zhang, Z., Ito, W. D., Hopfner, Ú., Böhmert, B., Kremer, M., Reckhenrich, A. K., Harder, Y., Lund, N., Kruse, C., Machens, H.-G., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.036 · Cited by 39
Heart regeneration with human pluripotent stem cells: Prospects and challenges
Jiang, Y., & Lian, X. L. (2020) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.01.003 · Cited by 42
Multicellular In vitro Models of Cardiac Arrhythmias: Focus on Atrial Fibrillation
van Gorp, P. R. R., Trines, S. A. I. P., Pijnappels, D. A., & de Vries, A. A. F. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00043 · Cited by 43
Bai, H., Xie, Y.-L., Gao, Y.-X., Cheng, T., & Wang, Z. Z. (2013) · Stem Cells and Development · doi:10.1089/scd.2013.0008 · Cited by 44
Cardiac tissue engineering using stem cells [Cellular/Tissue Engineering]
Bursac, N. (2009) · IEEE Engineering in Medicine and Biology Magazine · doi:10.1109/memb.2009.931792 · Cited by 42
Activin-A and Bmp4 Levels Modulate Cell Type Specification during CHIR-Induced Cardiomyogenesis
Kim, M.-S., Horst, A., Blinka, S., Stamm, K., Mahnke, D., Schuman, J., Gundry, R., Tomita-Mitchell, A., & Lough, J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118670 · Cited by 38
“3 shows that, consistent with the results described in S2 Fig. as PLOS ONE | DOI:10.1371/journal.pone.0118670 February 23, 2015 10 / 16 well as with previous findings in EBs [17,18], monolayered cells differentiated into either cardiomyocytes or DE as respectively driven by low or high levels of Activin-A.”
BackgroundMethodResultInfluentialChen, G., Li, S., Karakikes, I., Ren, L., Zi-Ying Chow, M., Chopra, A., Keung, W., Yan, B., Chan, C. W. Y., Costa, K. D., et al. (2015) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.114.002049 · Cited by 38
Nsair, A., Schenke‐Layland, K., Handel, B. V., Evseenko, D. A., Kahn, M., Zhao, P., Mendelis, J., Heydarkhan, S., Awaji, O., Vottler, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045603 · Cited by 38
Poon, E., Yan, B., Zhang, S., Rushing, S., Keung, W., Ren, L., Lieu, D. K., Geng, L., Kong, C.-W., Wang, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077784 · Cited by 37
“We performed directed cardiac differentiation as described previously [20] with cardiac derivatives making up ~50% of the cell population (Figure 1A).”
MethodDifferentiation and enrichment of cardiomyocytes from human pluripotent stem cells
Xu, C. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.03.012 · Cited by 40
Chow, M. Z. Y., Boheler, K. R., & Li, R. A. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt308 · Cited by 45
“The differentiating cells can be maintained in medium containing basic fibroblast growth factor, Dickkopf homolog 1, and vascular endothelial growth factor to support further cardiac lineage development [35].”
BackgroundDrowley, L., Koonce, C. H., Peel, S. E., Jonebring, A., Plowright, A. T., Kattman, S. J., Andersson, H., Anson, B. D., Swanson, B. J., Wang, Q., et al. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0114 · Cited by 38
Self-citationFreytes, D. O., O’Neill, J. D., Duan-Arnold, Y., Wrona, E. A., & Vunjak‐Novakovic, G. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1047-2_7 · Cited by 38
New models to study vascular mural cell embryonic origin: implications in vascular diseases
Sinha, S., & Santoro, M. M. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy005 · Cited by 39
Sa, S., Wong, L., & McCloskey, K. E. (2014) · BioResearch open access · doi:10.1089/biores.2014.0018 · Cited by 43
“…Wnt, Activin/Nodal, and bone morphogenetic protein (BMP) soluble signaling levels in cardiac differentiation protocols were identified as exhibiting variable levels of efficiency across the different hESC lines, 5,11–15 and a number of highly efficient cell line– specific protocols have been published.”
Peters, A., Burridge, P. W., Pryzhkova, M. V., Levine, M. A., Park, T. S., Roxbury, C. R., Yuan, X., Péault, B., & Zambidis, E. T. (2010) · The International Journal of Developmental Biology · doi:10.1387/ijdb.093043ap · Cited by 41
Jiang, B., Xiang, Z., Ai, Z., Wang, H., Li, Y., Ji, W., & Li, T. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.06.024 · Cited by 37
“Finally, from pdD12, the medium was changed into the maturation media, which was composed of IMDM/bFGF-free PSC-M (4:1) surplus with 5μg/ml Vitamin C. Monolayer differentiation of cardiomyocyte differentiation Mean 250μm sized hPSC-spheres were transferred onto 10μg/ml laminin-coated tissue culture dishes to induce CM…”
BackgroundInfluentialUosaki, H., Andersen, P., Shenje, L. T., Fernandez, L., Christiansen, S. L., & Kwon, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046413 · Cited by 37
Yang, C., French, A., Goh, P. A., Pagnamenta, A. T., Mettananda, S., Taylor, J. C., Knight, S. J. L., Nathwani, A. C., Roberts, D. J., Watt, S. M., et al. (2014) · British Journal of Haematology · doi:10.1111/bjh.12910 · Cited by 40
“British Journal of Haematology published by John Wiley & Sons Ltd. 445 British Journal of Haematology, 2014, 166, 435–448 has been shown to promote endothelial expansion in such cells (Yang et al, 2008) and is also known to promote erythropoiesis (Cerdan et al, 2004).”
BackgroundSox2 Transduction Enhances Cardiovascular Repair Capacity of Blood-Derived Mesoangioblasts
Koyanagi, M., Iwasaki, M., Rupp, S., Tedesco, F. S., Yoon, C., Boeckel, J., Trauth, J., Schütz, C., Ohtani, K., Goetz, R., et al. (2010) · Circulation Research · doi:10.1161/circresaha.109.206045 · Cited by 39
Human stem cells as a model for cardiac differentiation and disease
Beqqali, A., van Eldik, W. M., Mummery, C. L., & Passier, R. C. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-8476-0 · Cited by 39
El-Mounayri, O., Mihic, A., Shikatani, E. A., Gagliardi, M., Steinbach, S. K., Dubois, N. C., DaCosta, R. S., Li, R., Keller, G. M., & Husain, M. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs357 · Cited by 36
“To obtain monolayers of hESC-derived VSMCs, EBs were dissociated on d28 to single cells as described.(27) Dissociated cells were counted and plated on 0.”
MethodSelf-citationCardiac Progenitor Cells in Basic Biology and Regenerative Medicine
Witman, N., & Sahara, M. (2018) · Stem Cells International · doi:10.1155/2018/8283648 · Cited by 36
Heart regeneration using pluripotent stem cells
Kadota, S., Tanaka, Y., & Shiba, Y. (2020) · Journal of Cardiology · doi:10.1016/j.jjcc.2020.03.013 · Cited by 39
Progress and prospects in stem cell therapy
Xu, X., Yi, F., Pan, H., Duan, S., Ding, Z., Yuan, G., Qu, J. T., Zhang, H., & Liu, G. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.77 · Cited by 39
Lee, T., Jang, J., Kang, S., Jin, M. Y., Shin, H., Kim, D., & Kim, B. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.11.067 · Cited by 36
In vitro differentiation of rat embryonic stem cells into functional cardiomyocytes
Cao, N., Liao, J., Liu, Z., Zhu, W., Wang, J., Liu, L., Yu, L., Xu, P., Cui, C., Xiao, L., et al. (2011) · Cell Research · doi:10.1038/cr.2011.48 · Cited by 40
Human fetal cardiac progenitors: The role of stem cells and progenitors in the fetal and adult heart
Bulatović, I., Månsson‐Broberg, A., Sylvén, C., & Grinnemo, K. (2015) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2015.08.008 · Cited by 40
Optimizing Dynamic Interactions between a Cardiac Patch and Inflammatory Host Cells
Freytes, D. O., Santambrogio, L., & Vunjak‐Novakovic, G. (2011) · Cells Tissues Organs · doi:10.1159/000331392 · Cited by 36
Chemical approaches to studying stem cell biology
Li, W., Jiang, K., Wei, W., Shi, Y., & Ding, S. (2012) · Cell Research · doi:10.1038/cr.2012.182 · Cited by 39
Human-induced pluripotent stem cell-derived cardiomyocytes for studies of cardiac ion transporters
Fine, M., Lu, F.-M., Lin, M.-J., Moe, O. W., Wang, H.-R., & Hilgemann, D. W. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00143.2013 · Cited by 35
“In this light, cardiomyocytes derived from human-induced pluripotent stem cells (hiPSCs) by a number of different approaches (11, 13, 18, 38) are increasingly attractive models.”
BackgroundKamps, J. A. A. M., & Krenning, G. (2016) · World Journal of Cardiology · doi:10.4330/wjc.v8.i2.163 · Cited by 39
Liu, X., Qi, J., Xu, X., Zeisberg, M., Guan, K., & Zeisberg, E. M. (2016) · Differentiation · doi:10.1016/j.diff.2016.05.004 · Cited by 37
Cell Therapies in Cardiomyopathy: Current Status of Clinical Trials
Hao, M., Wang, R., & Wang, W. (2017) · Analytical Cellular Pathology · doi:10.1155/2017/9404057 · Cited by 37
Fujita, J., Tohyama, S., Kishino, Y., Okada, M., & Morita, Y. (2019) · Stem Cells · doi:10.1002/stem.3027 · Cited by 36
Engineering and Assessing Cardiac Tissue Complexity
Tadevosyan, K., Iglesias‐García, O., Mazo, M. M., Prósper, F., & Raya, Á. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031479 · Cited by 36
“Robust protocols have been developed for cardiac differentiation of PSCs allowing to obtain high yield of CMs [63,73,74].”
BackgroundeXtraembryonic ENdoderm (XEN) Stem Cells Produce Factors that Activate Heart Formation
Brown, K. J., Doss, M., Legros, S., Artus, J., Hadjantonakis, A., & Foley, A. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013446 · Cited by 36
“. Further support for this idea comes from a recently devised protocol in which the differentiation of human ES cells toward cardiomyocyte lineages is greatly enhanced as compared to untreated human ES cells.”
ResultPasquale, E. D., Latronico, M. V. G., Jotti, G. S., & Condorelli, G. (2012) · Gene Therapy · doi:10.1038/gt.2012.19 · Cited by 38
Regulation of the Microenvironment for Cardiac Tissue Engineering
Wanjare, M., & Huang, N. F. (2017) · Regenerative Medicine · doi:10.2217/rme-2016-0132 · Cited by 37
Takeda, M., Kanki, Y., Masumoto, H., Funakoshi, S., Hatani, T., Fukushima, H., Izumi-Taguchi, A., Matsui, Y., Shimamura, T., Yoshida, Y., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.057 · Cited by 38
“We analyzed the temporal expression pattern of two representative CPC surface markers, KDR and PDGFRa, and found that the KDRPDGFRa (KP) population (Kattman et al., 2011; Yang et al., 2008) prominently emerged from day 3 and peaked at day 5 in our system.”
BackgroundInfluentialChiu, L. L. Y., & Radisic, M. (2013) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2013.01.002 · Cited by 44
Synergistic effects of hypoxia and extracellular matrix cues in cardiomyogenesis
Horton, R. E., & Auguste, D. T. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.05.063 · Cited by 38
Induced pluripotent stem cell-derived cardiomyocytes as models for genetic cardiovascular disorders
Josowitz, R., Carvajal‐Vergara, X., Lemischka, I. R., & Gelb, B. D. (2011) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32834598ad · Cited by 39
Differentiation of pluripotent stem cells for regenerative medicine
Li, K., Kong, Y., Zhang, M., Xie, F., Liu, P., & Xu, S. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.01.182 · Cited by 34
Jeziorowska, D., Fontaine, V., Jouve, C., Villard, E., Dussaud, S., Akbar, D., Letang, V., Cervello, P., Itier, J.-M., Pruniaux, M., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061173 · Cited by 36
“This protocol originates from the seminal report from Keller’s group [18] and has been largely used in different research projects to model cardiomyopathies.”
MethodYoon, C., Song, H., Yin, T., Bausch‐Fluck, D., Frei, A. P., Kattman, S. J., Dubois, N. C., Witty, A. D., Hewel, J. A., Guo, H., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.11.008 · Cited by 37
“Higher CM Output from FZD4 CPCs Is Also Observed during hPSC Differentiation To determine whether FZD4 abundance patterns and signaling effects were conserved in hPSCs, we generated hPSC-derived CPCs in a similar BMP/ACTIVIN A-induced system (Yang et al., 2008).”
BackgroundSelf-citationMolecular basis of functional myogenic specification ofBona Fidemultipotent adult cardiac stem cells
Cianflone, E., Aquila, I., Scalise, M., Marotta, P., Torella, M., Nadal‐Ginard, B., & Torella, D. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1464852 · Cited by 36
Ni, X., Xu, K., Zhao, Y., Li, J., Wang, L., Yu, F., & Li, G. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.11.076 · Cited by 35
Strategies in cardiac tissue engineering
Tee, R., Lokmic‐Tomkins, Z., Morrison, W. A., & Dilley, R. J. (2010) · ANZ Journal of Surgery · doi:10.1111/j.1445-2197.2010.05435.x · Cited by 37
“ESC pluripotency permits their differentiation into all components of the myocardium: CMs, fibroblasts and endothelial cells (EC).(43) Spontaneously contractile cardiac tissues can be generated using human ESC-derived CMs, and in vivo studies in rodent models have shown promising preliminary results.”
BackgroundCurrent-Controlled Electrical Point-Source Stimulation of Embryonic Stem Cells
Chen, M. Q., Xie, X., Wilson, K. D., Sun, N., Wu, J. C., Giovangrandi, L., & Kovacs, G. T. A. (2009) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-009-0096-0 · Cited by 34
Kim, Y. Y., Ku, S., Liu, H.-C., Cho, H., Oh, S. K., Moon, S. Y., & Choi, Y. M. (2011) · Reproductive Sciences · doi:10.1177/1933719110385130 · Cited by 38
“Numerous studies indicated the differentiation yield by providing the proportion of positive cells for specific markers.(7,10,11,26) These criteria are not convincing from a functional viewpoint, because marker expression could also be observed from nonbeating CMs.”
BackgroundBraam, S. R., Nauw, R., Oostwaard, D. W., Mummery, C. L., & Passier, R. C. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05083.x · Cited by 36
Tissue engineering bioreactor systems for applying physical and electrical stimulations to cells
Jin, G., Yang, G. H., & Kim, G. (2014) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.33268 · Cited by 35
Embryonic and embryonic-like stem cells in heart muscle engineering
Zimmermann, W. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.027 · Cited by 36
In vitro organogenesis from pluripotent stem cells
Li, Y., Xu, C., & Ma, T. (2014) · Organogenesis · doi:10.4161/org.28918 · Cited by 31
“With specific inducing medium and growth factors, the EB composition can be modulated toward a particular lineage such as cardiomyocytes.(14) Extracellular matrix Cells in the 3-D aggregates of PSCs produce large amounts of extracellular matrices which may carry the signaling molecules and autocrine/paracrine factors…”
BackgroundRegenerative Medicine for the Heart: Perspectives on Stem-Cell Therapy
Cho, G.-S., Fernandez, L., & Kwon, C. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6063 · Cited by 37
“PSC-derived CPCs can be isolated using cell-surface markers, such as KDR and/or PDGFRA (53, 150).”
Rahman, N., Brauer, P. M., Ho, L., Usenko, T. S., Tewary, M., Zúñiga‐Pflücker, J. C., & Zandstra, P. W. (2017) · Nature Communications · doi:10.1038/ncomms15380 · Cited by 33
Cui, X., Shang, S., Lv, X., Zhao, J., Qi, Y., & Liu, Z. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10209 · Cited by 40
“Human iPSc and eSc translational studies have indicated that the co-expression of platelet derived growth factor receptor a and kinase insert domain protein receptor directs the emergence of the cardiac mesoderm, and that this is dependent on the optimal levels of BMP and activin/nodal signaling (70,76).”
BackgroundXuan, W., Wang, L., Xu, M., Weintraub, N. L., & Ashraf, M. (2019) · Stem Cells International · doi:10.1155/2019/3726392 · Cited by 33
Tsujisaka, Y., Hatani, T., Okubo, C., Ito, R., Kimura, A., Narita, M., Chonabayashi, K., Funakoshi, S., Lucena-Cacace, A., Toyoda, T., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.05.003 · Cited by 34
Single-cell transcript analysis of human embryonic stem cells
Gibson, J. D., Jakuba, C. M., Boucher, N., Holbrook, K., Carter, M. G., & Nelson, C. E. (2009) · Integrative Biology · doi:10.1039/b908276j · Cited by 37
Carbon nanotube-based substrates for modulation of human pluripotent stem cell fate
Pryzhkova, M. V., Aria, A. I., Cheng, Q., Harris, G. M., Zan, X., Gharib, M., & Jabbarzadeh, E. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.011 · Cited by 35
“Although KDR gene expression was detected in undifferentiated hESCs [46,47] and altered during the differentiation process (Fig.”
BackgroundBioengineering heart tissue for in vitro testing
Cimetta, E., Godier-Furnémont, A., & Vunjak-Novakovic, G. (2013) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2013.07.002 · Cited by 32
“Keller group was the first one to implement in vitro the regulation of Activin/Nodal and BMP pathways in human stem cells to generate cardiac mesoderm, and stagespecific induction/inhibition towards cardiac specification [14 ,15,16 ,17,18].”
Global DNA methylation and transcriptional analyses of human ESC-derived cardiomyocytes
Gu, Y., Liu, G., Plongthongkum, N., Benner, C. W., Yi, F., Qu, J. T., Suzuki, K., Yang, J., Zhang, W., Li, M., et al. (2013) · Protein & Cell · doi:10.1007/s13238-013-0016-x · Cited by 33
“Recent efforts have successfully developed several protocols, by which hESCs can be differentiated into hCMs (Yang et al., 2008; Kattman et al., 2011; Lian et al., 2012; Willems et al., Electronic supplementary material The online version of this article (doi:10.1007/s13238-013-0016-x) contains…”
BackgroundInfluentialFunctions of BMP signaling in embryonic stem cell fate determination
Li, Z., & Chen, Y. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.09.016 · Cited by 39
Cardiomyocytes from human embryonic stem cells as predictors of cardiotoxicity
Denning, C. N., & Anderson, D. (2008) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2008.08.002 · Cited by 36
Metadata
- Authors
- Yang, L., Soonpaa, M. H., Adler, E. D., Roepke, T. K., Kattman, S. J., Kennedy, M., Henckaerts, E., Bonham, K., Abbott, G. W., Linden, R. M., Field, L. J., & Keller, G. M.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Indiana University School of Medicine (US)
- Cornell University (US)
- University Health Network (CA)
- King's College London (GB)
- VistaGen Therapeutics (United States) (US)
- Corresponding author
- Keller, Gordon M.
- ORCID
- Venue
- Nature
- Published
- 2008-04-23
- Volume
- 453
- Issue
- 7194
- Pages
- 524-528
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2010417854
- Cited by
- 1,389
- References
- 30
- Citations by year
- 2026: 17 · 2025: 20 · 2024: 20 · 2023: 33 · 2022: 45 · 2021: 60 · 2020: 65 · 2019: 59 · 2018: 66 · 2017: 89 · 2016: 79 · 2015: 107 · 2014: 114 · 2013: 141 · 2012: 146
- FWCI
- 45.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Lirias (submittedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL079275, R01HL083126)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- human embryonic stem cells, cardiac progenitor cells, KDR, Flk-1, cardiomyocyte differentiation, endothelial differentiation, vascular smooth muscle cell differentiation, mesoderm specification, heart development, embryoid bodies, cell transplantation, cardiac regeneration, cardiovascular tissue engineering, lineage tracing, clonal origin, growth factor cocktail, activin A, BMP4, basic fibroblast growth factor
- MeSH terms
- Cell Differentiation, Cell Line, Humans, Fibroblast Growth Factor 2, Patch-Clamp Techniques, Proto-Oncogene Proteins c-kit, Cell Lineage, Bone Morphogenetic Proteins, Activins, Myocytes, Cardiac, Intercellular Signaling Peptides and Proteins, Vascular Endothelial Growth Factor Receptor-2, Vascular Endothelial Growth Factor A, Embryonic Stem Cells, Bone Morphogenetic Protein 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.